Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2028

Conditions

Burns

Interventions

BIOLOGICAL

denovoSkin(TM)

Transplantation of autologous dermo-epidermal skin substitute denovoSkin(TM) to the experimental area

OTHER

STSG

Transplantation of autologous split-thickness skin to the control area

Trial Locations (1)

RECRUITING

Rode Kruis Ziekenhuis, Beverwijk

All Listed Sponsors

collaborator

RCTs

INDUSTRY

lead

CUTISS AG

INDUSTRY